Novel antiplatelet and anticoagulant agents in the cardiac care unit.
Cardiol Clin. 2013 Nov;31(4):533-44
Authors: Garg VP, Halperin JL
This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.
PMID: 24188219 [PubMed - in process]